Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Researchers Recommend Replacing Heart Valves That Are Failing, Even If No Symptoms Experienced Despite concerns over TAVR risks, researchers found it is usually preferable to deal with severe aortic stenosis quickly, instead of waiting to see how the condition progresses. November 1, 2024 Martha Garcia Add Your Comments For decades, doctors have called for a “wait and see” approach for treatment of failing heart valves, thinking that transcatheter aortic valve replacement (TAVR) surgery was too risky. However, new research calls that practice into question, suggesting that it may be better to replace failing heart valves as early as possible. In findings published this week in the New England Journal of Medicine, researchers from Morristown Medical Center in New Jersey indicate that patients who undergo heart valve replacement instead of having doctors monitor their condition for several years, face a lower risk of suffering cardiovascular side effects like stroke. In addition, the study found that the risk of hospitalization was cut nearly in half with the use of transcatheter aortic valve replacement when compared to those in the surveillance group. TAVR is a procedure where the heart valve is replaced by threading it through an artery in the leg instead of via open chest surgery. It places the valve directly over the damaged aortic valve in a less invasive procedure, which is why it is often favored by doctors. However, instead of first looking to TAVR, doctors often use a watch-and-wait approach when treating people who suffer from asymptomatic severe aortic stenosis, or a severe narrowing of the heart valve that controls blood flow from the heart. The condition often has a worse outcome for patients than most cancers and roughly 3% of people over 65 years old will suffer from the condition. Typically, physicians wait to conduct a TAVR or perform a minimally invasive heart valve replacement with a balloon threaded through the groin, instead of open heart surgery. Current guidelines call for surveillance every six to 12 months before surgery is recommended, given the risk nature of the procedures. However, that may no longer be the best approach. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In the new study, a team led by Dr. Phillippe Généreux studied more than 900 patients with failing heart valves across 75 medical centers in the U.S. and Canada. Half were assigned to doctor surveillance and the other half were given an early TAVR surgery to replace the heart valve. Overall, 27% of patients who had heart valve replacement surgery suffered side effects like a stroke or were hospitalized early. Comparatively, 45% of the surveillance group experienced those complications. The death rate among surgical patients was 8% and among surveillance patients, it was 9%. More so, only 4% of the surgical patients had a stroke, compared to 7% of the surveillance patients. Unplanned hospitalization rates were 21% in the TAVR surgery group and 42% in the surveillance group. The researchers noted that 87% of patients assigned to the “wait and see” surveillance group ended up needing surgery to have a heart valve replacement anyway. They often had to undergo the surgery within two years. Researchers said this suggests the heart condition may get worse more quickly than was previously believed. In the long run, patients who underwent valve replacement earlier were better off and faced a lower risk of cardiovascular side effects, hospitalization and death. “Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes,” wrote study authors. Prior studies indicated heart valves used in the TAVR surgery may deteriorate more rapidly, especially among patients with kidney disease. More research is needed to examine the durability of the replacement heart valves, especially among patients who may be younger and will need to have the valves in place longer. However, the approach for active surveillance among heart patients may not be the best course of action, Généreux’s team determined. They recommended doctors weigh the risks and benefits of early TAVR surgery for patients with failing heart valves. Tags: Aortic Stenosis, Doctors, Heart Surgery, TAVR Image Credit: Shutterstock: Christian Bertrand More Lawsuit Stories New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement April 3, 2025 Food Manufacturers Seek Dismissal of Ultra-Processed Food Childhood Diabetes Lawsuit April 3, 2025 Flavored Vape Restrictions Upheld by Supreme Court April 3, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (Posted: today) In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery. MORE ABOUT: HERNIA MESH LAWSUITHernia Surgery Malpractice Lawsuit Cleared To Move Forward Over Botched Procedure (03/21/2025)Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (03/14/2025)Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025) Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: yesterday) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 2 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (Posted: today) In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery. MORE ABOUT: HERNIA MESH LAWSUITHernia Surgery Malpractice Lawsuit Cleared To Move Forward Over Botched Procedure (03/21/2025)Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (03/14/2025)Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: yesterday) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 2 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)